Global Thrombin (Human) Market Insights and Forecast to 2026

Global Thrombin (Human) Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Thrombin (Human) Product Introduction
1.2 Market Segments
1.3 Key Thrombin (Human) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Thrombin (Human) Market Size Growth Rate by Type
1.4.2 500IU/Vial
1.4.3 1000IU/Vial
1.4.4 2500IU/Vial
1.5 Market by Application
1.5.1 Global Thrombin (Human) Market Size Growth Rate by Application
1.5.2 Biotechnology
1.5.3 Medicine
1.5.4 Microbiology
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Thrombin (Human) Market Size, Estimates and Forecasts
2.1.1 Global Thrombin (Human) Revenue 2015-2026
2.1.2 Global Thrombin (Human) Sales 2015-2026
2.2 Global Thrombin (Human), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Thrombin (Human) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Thrombin (Human) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Thrombin (Human) Competitor Landscape by Players
3.1 Thrombin (Human) Sales by Manufacturers
3.1.1 Thrombin (Human) Sales by Manufacturers (2015-2020)
3.1.2 Thrombin (Human) Sales Market Share by Manufacturers (2015-2020)
3.2 Thrombin (Human) Revenue by Manufacturers
3.2.1 Thrombin (Human) Revenue by Manufacturers (2015-2020)
3.2.2 Thrombin (Human) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Thrombin (Human) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Thrombin (Human) Revenue in 2019
3.2.5 Global Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Thrombin (Human) Price by Manufacturers
3.4 Thrombin (Human) Manufacturing Base Distribution, Product Types
3.4.1 Thrombin (Human) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Thrombin (Human) Product Type
3.4.3 Date of International Manufacturers Enter into Thrombin (Human) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Thrombin (Human) Market Size by Type (2015-2020)
4.1.1 Global Thrombin (Human) Sales by Type (2015-2020)
4.1.2 Global Thrombin (Human) Revenue by Type (2015-2020)
4.1.3 Thrombin (Human) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Thrombin (Human) Market Size Forecast by Type (2021-2026)
4.2.1 Global Thrombin (Human) Sales Forecast by Type (2021-2026)
4.2.2 Global Thrombin (Human) Revenue Forecast by Type (2021-2026)
4.2.3 Thrombin (Human) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Thrombin (Human) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Thrombin (Human) Market Size by Application (2015-2020)
5.1.1 Global Thrombin (Human) Sales by Application (2015-2020)
5.1.2 Global Thrombin (Human) Revenue by Application (2015-2020)
5.1.3 Thrombin (Human) Price by Application (2015-2020)
5.2 Thrombin (Human) Market Size Forecast by Application (2021-2026)
5.2.1 Global Thrombin (Human) Sales Forecast by Application (2021-2026)
5.2.2 Global Thrombin (Human) Revenue Forecast by Application (2021-2026)
5.2.3 Global Thrombin (Human) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Thrombin (Human) by Country
6.1.1 North America Thrombin (Human) Sales by Country
6.1.2 North America Thrombin (Human) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Thrombin (Human) Market Facts & Figures by Type
6.3 North America Thrombin (Human) Market Facts & Figures by Application
7 Europe
7.1 Europe Thrombin (Human) by Country
7.1.1 Europe Thrombin (Human) Sales by Country
7.1.2 Europe Thrombin (Human) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Thrombin (Human) Market Facts & Figures by Type
7.3 Europe Thrombin (Human) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Thrombin (Human) by Region
8.1.1 Asia Pacific Thrombin (Human) Sales by Region
8.1.2 Asia Pacific Thrombin (Human) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Thrombin (Human) Market Facts & Figures by Type
8.3 Asia Pacific Thrombin (Human) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Thrombin (Human) by Country
9.1.1 Latin America Thrombin (Human) Sales by Country
9.1.2 Latin America Thrombin (Human) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Thrombin (Human) Market Facts & Figures by Type
9.3 Central & South America Thrombin (Human) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Thrombin (Human) by Country
10.1.1 Middle East and Africa Thrombin (Human) Sales by Country
10.1.2 Middle East and Africa Thrombin (Human) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Thrombin (Human) Market Facts & Figures by Type
10.3 Middle East and Africa Thrombin (Human) Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Thrombin (Human) Products Offered
11.1.5 Baxter Related Developments
11.2 AMRESCO Inc
11.2.1 AMRESCO Inc Corporation Information
11.2.2 AMRESCO Inc Description and Business Overview
11.2.3 AMRESCO Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AMRESCO Inc Thrombin (Human) Products Offered
11.2.5 AMRESCO Inc Related Developments
11.3 BD Biosciences
11.3.1 BD Biosciences Corporation Information
11.3.2 BD Biosciences Description and Business Overview
11.3.3 BD Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BD Biosciences Thrombin (Human) Products Offered
11.3.5 BD Biosciences Related Developments
11.4 Life Technologies Corporation
11.4.1 Life Technologies Corporation Corporation Information
11.4.2 Life Technologies Corporation Description and Business Overview
11.4.3 Life Technologies Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Life Technologies Corporation Thrombin (Human) Products Offered
11.4.5 Life Technologies Corporation Related Developments
11.5 PromoCell GmbH
11.5.1 PromoCell GmbH Corporation Information
11.5.2 PromoCell GmbH Description and Business Overview
11.5.3 PromoCell GmbH Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PromoCell GmbH Thrombin (Human) Products Offered
11.5.5 PromoCell GmbH Related Developments
11.6 Sigma-Aldrich Corporation
11.6.1 Sigma-Aldrich Corporation Corporation Information
11.6.2 Sigma-Aldrich Corporation Description and Business Overview
11.6.3 Sigma-Aldrich Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sigma-Aldrich Corporation Thrombin (Human) Products Offered
11.6.5 Sigma-Aldrich Corporation Related Developments
11.7 Vitrolife AB
11.7.1 Vitrolife AB Corporation Information
11.7.2 Vitrolife AB Description and Business Overview
11.7.3 Vitrolife AB Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Vitrolife AB Thrombin (Human) Products Offered
11.7.5 Vitrolife AB Related Developments
11.8 CSL
11.8.1 CSL Corporation Information
11.8.2 CSL Description and Business Overview
11.8.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.8.4 CSL Thrombin (Human) Products Offered
11.8.5 CSL Related Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description and Business Overview
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Thrombin (Human) Products Offered
11.9.5 Bayer Related Developments
11.10 Grifols
11.10.1 Grifols Corporation Information
11.10.2 Grifols Description and Business Overview
11.10.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Grifols Thrombin (Human) Products Offered
11.10.5 Grifols Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Thrombin (Human) Products Offered
11.1.5 Baxter Related Developments
11.12 Shanghai RAAS
11.12.1 Shanghai RAAS Corporation Information
11.12.2 Shanghai RAAS Description and Business Overview
11.12.3 Shanghai RAAS Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Shanghai RAAS Products Offered
11.12.5 Shanghai RAAS Related Developments
11.13 Hualan Biological
11.13.1 Hualan Biological Corporation Information
11.13.2 Hualan Biological Description and Business Overview
11.13.3 Hualan Biological Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Hualan Biological Products Offered
11.13.5 Hualan Biological Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Thrombin (Human) Market Estimates and Projections by Region
12.1.1 Global Thrombin (Human) Sales Forecast by Regions 2021-2026
12.1.2 Global Thrombin (Human) Revenue Forecast by Regions 2021-2026
12.2 North America Thrombin (Human) Market Size Forecast (2021-2026)
12.2.1 North America: Thrombin (Human) Sales Forecast (2021-2026)
12.2.2 North America: Thrombin (Human) Revenue Forecast (2021-2026)
12.2.3 North America: Thrombin (Human) Market Size Forecast by Country (2021-2026)
12.3 Europe Thrombin (Human) Market Size Forecast (2021-2026)
12.3.1 Europe: Thrombin (Human) Sales Forecast (2021-2026)
12.3.2 Europe: Thrombin (Human) Revenue Forecast (2021-2026)
12.3.3 Europe: Thrombin (Human) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Thrombin (Human) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Thrombin (Human) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Thrombin (Human) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Thrombin (Human) Market Size Forecast by Region (2021-2026)
12.5 Latin America Thrombin (Human) Market Size Forecast (2021-2026)
12.5.1 Latin America: Thrombin (Human) Sales Forecast (2021-2026)
12.5.2 Latin America: Thrombin (Human) Revenue Forecast (2021-2026)
12.5.3 Latin America: Thrombin (Human) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Thrombin (Human) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Thrombin (Human) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Thrombin (Human) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Thrombin (Human) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Thrombin (Human) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Thrombin (Human) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Thrombin (Human) Market Segments
Table 2. Ranking of Global Top Thrombin (Human) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Thrombin (Human) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 500IU/Vial
Table 5. Major Manufacturers of 1000IU/Vial
Table 6. Major Manufacturers of 2500IU/Vial
Table 7. Global Thrombin (Human) Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Thrombin (Human) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Thrombin (Human) Sales by Regions 2015-2020 (K Units)
Table 10. Global Thrombin (Human) Sales Market Share by Regions (2015-2020)
Table 11. Global Thrombin (Human) Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Thrombin (Human) Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Thrombin (Human) Sales Share by Manufacturers (2015-2020)
Table 14. Global Thrombin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Thrombin (Human) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombin (Human) as of 2019)
Table 16. Thrombin (Human) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Thrombin (Human) Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Thrombin (Human) Price (2015-2020) (USD/Unit)
Table 19. Thrombin (Human) Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Thrombin (Human) Product Type
Table 21. Date of International Manufacturers Enter into Thrombin (Human) Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Thrombin (Human) Sales by Type (2015-2020) (K Units)
Table 24. Global Thrombin (Human) Sales Share by Type (2015-2020)
Table 25. Global Thrombin (Human) Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Thrombin (Human) Revenue Share by Type (2015-2020)
Table 27. Thrombin (Human) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Thrombin (Human) Sales by Application (2015-2020) (K Units)
Table 29. Global Thrombin (Human) Sales Share by Application (2015-2020)
Table 30. North America Thrombin (Human) Sales by Country (2015-2020) (K Units)
Table 31. North America Thrombin (Human) Sales Market Share by Country (2015-2020)
Table 32. North America Thrombin (Human) Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Thrombin (Human) Revenue Market Share by Country (2015-2020)
Table 34. North America Thrombin (Human) Sales by Type (2015-2020) (K Units)
Table 35. North America Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 36. North America Thrombin (Human) Sales by Application (2015-2020) (K Units)
Table 37. North America Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 38. Europe Thrombin (Human) Sales by Country (2015-2020) (K Units)
Table 39. Europe Thrombin (Human) Sales Market Share by Country (2015-2020)
Table 40. Europe Thrombin (Human) Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Thrombin (Human) Revenue Market Share by Country (2015-2020)
Table 42. Europe Thrombin (Human) Sales by Type (2015-2020) (K Units)
Table 43. Europe Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 44. Europe Thrombin (Human) Sales by Application (2015-2020) (K Units)
Table 45. Europe Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Thrombin (Human) Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Thrombin (Human) Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Thrombin (Human) Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Thrombin (Human) Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Thrombin (Human) Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Thrombin (Human) Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 54. Latin America Thrombin (Human) Sales by Country (2015-2020) (K Units)
Table 55. Latin America Thrombin (Human) Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Thrombin (Human) Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Thrombin (Human) Revenue Market Share by Country (2015-2020)
Table 58. Latin America Thrombin (Human) Sales by Type (2015-2020) (K Units)
Table 59. Latin America Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 60. Latin America Thrombin (Human) Sales by Application (2015-2020) (K Units)
Table 61. Latin America Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Thrombin (Human) Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Thrombin (Human) Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Thrombin (Human) Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Thrombin (Human) Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Thrombin (Human) Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Thrombin (Human) Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Thrombin (Human) Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Thrombin (Human) Sales Market Share by Application (2015-2020)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Major Businesses
Table 72. Baxter Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Baxter Product
Table 74. Baxter Recent Development
Table 75. AMRESCO Inc Corporation Information
Table 76. AMRESCO Inc Description and Major Businesses
Table 77. AMRESCO Inc Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. AMRESCO Inc Product
Table 79. AMRESCO Inc Recent Development
Table 80. BD Biosciences Corporation Information
Table 81. BD Biosciences Description and Major Businesses
Table 82. BD Biosciences Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. BD Biosciences Product
Table 84. BD Biosciences Recent Development
Table 85. Life Technologies Corporation Corporation Information
Table 86. Life Technologies Corporation Description and Major Businesses
Table 87. Life Technologies Corporation Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Life Technologies Corporation Product
Table 89. Life Technologies Corporation Recent Development
Table 90. PromoCell GmbH Corporation Information
Table 91. PromoCell GmbH Description and Major Businesses
Table 92. PromoCell GmbH Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. PromoCell GmbH Product
Table 94. PromoCell GmbH Recent Development
Table 95. Sigma-Aldrich Corporation Corporation Information
Table 96. Sigma-Aldrich Corporation Description and Major Businesses
Table 97. Sigma-Aldrich Corporation Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sigma-Aldrich Corporation Product
Table 99. Sigma-Aldrich Corporation Recent Development
Table 100. Vitrolife AB Corporation Information
Table 101. Vitrolife AB Description and Major Businesses
Table 102. Vitrolife AB Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Vitrolife AB Product
Table 104. Vitrolife AB Recent Development
Table 105. CSL Corporation Information
Table 106. CSL Description and Major Businesses
Table 107. CSL Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. CSL Product
Table 109. CSL Recent Development
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bayer Product
Table 114. Bayer Recent Development
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Major Businesses
Table 117. Grifols Thrombin (Human) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Grifols Product
Table 119. Grifols Recent Development
Table 120. Octapharma Corporation Information
Table 121. Octapharma Description and Major Businesses
Table 122. Octapharma Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Octapharma Product
Table 124. Octapharma Recent Development
Table 125. Shanghai RAAS Corporation Information
Table 126. Shanghai RAAS Description and Major Businesses
Table 127. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Shanghai RAAS Product
Table 129. Shanghai RAAS Recent Development
Table 130. Hualan Biological Corporation Information
Table 131. Hualan Biological Description and Major Businesses
Table 132. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Hualan Biological Product
Table 134. Hualan Biological Recent Development
Table 135. Global Thrombin (Human) Sales Forecast by Regions (2021-2026) (K Units)
Table 136. Global Thrombin (Human) Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Thrombin (Human) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Thrombin (Human) Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Thrombin (Human) Sales Forecast by Country (2021-2026) (K Units)
Table 140. North America: Thrombin (Human) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Thrombin (Human) Sales Forecast by Country (2021-2026) (K Units)
Table 142. Europe: Thrombin (Human) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Thrombin (Human) Sales Forecast by Region (2021-2026) (K Units)
Table 144. Asia Pacific: Thrombin (Human) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Thrombin (Human) Sales Forecast by Country (2021-2026) (K Units)
Table 146. Latin America: Thrombin (Human) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Thrombin (Human) Sales Forecast by Country (2021-2026) (K Units)
Table 148. Middle East and Africa: Thrombin (Human) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Thrombin (Human) Players
Table 153. Thrombin (Human) Customers List
Table 154. Thrombin (Human) Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombin (Human) Product Picture
Figure 2. Global Thrombin (Human) Sales Market Share by Type in 2020 & 2026
Figure 3. 500IU/Vial Product Picture
Figure 4. 1000IU/Vial Product Picture
Figure 5. 2500IU/Vial Product Picture
Figure 6. Global Thrombin (Human) Sales Market Share by Application in 2020 & 2026
Figure 7. Biotechnology
Figure 8. Medicine
Figure 9. Microbiology
Figure 10. Other
Figure 11. Thrombin (Human) Report Years Considered
Figure 12. Global Thrombin (Human) Market Size 2015-2026 (US$ Million)
Figure 13. Global Thrombin (Human) Sales 2015-2026 (K Units)
Figure 14. Global Thrombin (Human) Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Thrombin (Human) Sales Market Share by Region (2015-2020)
Figure 16. Global Thrombin (Human) Sales Market Share by Region in 2019
Figure 17. Global Thrombin (Human) Revenue Market Share by Region (2015-2020)
Figure 18. Global Thrombin (Human) Revenue Market Share by Region in 2019
Figure 19. Global Thrombin (Human) Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Thrombin (Human) Revenue in 2019
Figure 21. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Thrombin (Human) Sales Market Share by Type (2015-2020)
Figure 23. Global Thrombin (Human) Sales Market Share by Type in 2019
Figure 24. Global Thrombin (Human) Revenue Market Share by Type (2015-2020)
Figure 25. Global Thrombin (Human) Revenue Market Share by Type in 2019
Figure 26. Global Thrombin (Human) Market Share by Price Range (2015-2020)
Figure 27. Global Thrombin (Human) Sales Market Share by Application (2015-2020)
Figure 28. Global Thrombin (Human) Sales Market Share by Application in 2019
Figure 29. Global Thrombin (Human) Revenue Market Share by Application (2015-2020)
Figure 30. Global Thrombin (Human) Revenue Market Share by Application in 2019
Figure 31. North America Thrombin (Human) Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Thrombin (Human) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Thrombin (Human) Sales Market Share by Country in 2019
Figure 34. North America Thrombin (Human) Revenue Market Share by Country in 2019
Figure 35. U.S. Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Thrombin (Human) Market Share by Type in 2019
Figure 40. North America Thrombin (Human) Market Share by Application in 2019
Figure 41. Europe Thrombin (Human) Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Thrombin (Human) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Thrombin (Human) Sales Market Share by Country in 2019
Figure 44. Europe Thrombin (Human) Revenue Market Share by Country in 2019
Figure 45. Germany Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Thrombin (Human) Market Share by Type in 2019
Figure 56. Europe Thrombin (Human) Market Share by Application in 2019
Figure 57. Asia Pacific Thrombin (Human) Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Thrombin (Human) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Thrombin (Human) Sales Market Share by Region in 2019
Figure 60. Asia Pacific Thrombin (Human) Revenue Market Share by Region in 2019
Figure 61. China Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Thrombin (Human) Market Share by Type in 2019
Figure 84. Asia Pacific Thrombin (Human) Market Share by Application in 2019
Figure 85. Latin America Thrombin (Human) Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Thrombin (Human) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Thrombin (Human) Sales Market Share by Country in 2019
Figure 88. Latin America Thrombin (Human) Revenue Market Share by Country in 2019
Figure 89. Mexico Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Thrombin (Human) Market Share by Type in 2019
Figure 96. Latin America Thrombin (Human) Market Share by Application in 2019
Figure 97. Middle East and Africa Thrombin (Human) Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Thrombin (Human) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Thrombin (Human) Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Thrombin (Human) Revenue Market Share by Country in 2019
Figure 101. Turkey Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Thrombin (Human) Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Thrombin (Human) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Thrombin (Human) Market Share by Type in 2019
Figure 108. Middle East and Africa Thrombin (Human) Market Share by Application in 2019
Figure 109. North America Thrombin (Human) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Thrombin (Human) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Thrombin (Human) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Thrombin (Human) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Thrombin (Human) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Thrombin (Human) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Thrombin (Human) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Thrombin (Human) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Thrombin (Human) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Thrombin (Human) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs